Owens & Minor and Rotech Healthcare Agree to Terminate Acquisition Amid Regulatory Challenges

Reuters
Jun 05
Owens & Minor and Rotech Healthcare Agree to Terminate Acquisition Amid Regulatory Challenges

Owens & Minor Inc. has announced the mutual termination of its previously planned acquisition of Rotech Healthcare Holdings Inc. As per the merger agreement, Owens & Minor has paid Rotech Healthcare $80 million. The company will also redeem the $1 billion of notes issued in April 2025 and terminate the related loan commitments that were intended for the acquisition. Edward A. Pesicka, President & CEO of Owens & Minor, stated that despite the potential benefits of the merger, obtaining regulatory clearance proved too challenging. Owens & Minor will continue its focus on growing its Patient Direct business and strengthening its balance sheet by leveraging improved cash flow for deleveraging. The company remains committed to the home-based care market and is exploring potential sales of its Products and Healthcare Services business.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Owens & Minor Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250605151653) on June 05, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10